CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to reduce deadly uncontrolled inflammation in...

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members of its leadership team will be making...

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it will present...

Visit VITEC at IBC2015, Stand 7.G16 VITEC Contact: Peer Jambor Marketing and Communications Manager Tel: +1 (404) 320-0110 x 123 Email: peer.jambor@vitec.com Media Contact: Peggy Blaze InGear Tel:...